Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Blueberries Medical Co. (OP:BBRRF)

0.0126 +0.0016 (+14.55%)
Streaming Delayed Price Updated: 10:25 AM EDT, Sep 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Blueberries Medical Co.

< Previous 1 2 3 4 5 6 7 8 9 Next >
Cannabis Stock Gainers And Losers From July 28, 2023
 
Via Benzinga
Cannabis Stock Gainers And Losers From July 25, 2023
 
Via Benzinga
Cannabis Stock Gainers And Losers From July 26, 2023
 
Via Benzinga
Cannabis Stock Movers For July 21, 2023
 
Via Benzinga
Cannabis Stock Movers For July 24, 2023
 
Via Benzinga
Cannabis Stock Gainers And Losers From July 18, 2023
 
Via Benzinga
Cannabis Stock Movers For July 20, 2023
 
Via Benzinga
Cannabis Stock Gainers And Losers From July 14, 2023
 
Via Benzinga
Cannabis Stock Movers For July 19, 2023
 
Via Benzinga
Bullish Thursday For Marijuana Stocks - Choom Holdings, EVIO Among Top Gainers
 
Via Benzinga
Cannabis Stock Movers For July 10, 2023
 
Via Benzinga
Blueberries Medical Reports Q1-2023
Financial Results, Expands Deals, Achieves Revenue Growth, Enhances Cost Efficiency, and Announces Board and Executive Updates 
From Blueberries Medical Corp.
Via GlobeNewswire
Allied Corp Teams Up With Blueberries Medical To Produce Psychoactive And Non-Psychoactive Derivatives
Allied Corp. (OTCQB: ALID), a cannabis cultivator based in Colombia and one of the few to have executed on international exports, announced that it has signed a joint venture agreement with Blueberries... 
Via Benzinga
Blueberries Medical Reports 2022 Financial Results
From Blueberries Medical Corp.
Via GlobeNewswire
Blueberries Medical Announces Closing of US$1.1 Million Non-Brokered Private Placement, reports 2022 Q3 Financial Results and provides Corporate and Operations Update
From Blueberries Medical Corp.
Via GlobeNewswire
Blueberries Medical Q2 Revenue Grows 169%, What About Net Loss?
Blueberries Medical Corp. (OTCQB: BBRRF) (CSE:BBM) (FRA:1OA) released its financial results for the quarter ended on June 30, 2022, revealing total revenue of CA$39,826, an increase of CA$25,041 (or... 
Via Benzinga
Blueberries Provides Corporate Update, Extends Maturity Date Of Convertible Debentures
Blueberries Medical Corp. (OTCQB: BBRRF) (CSE:BBM) (FRA:1OA) has achieved several CBD and non-psychoactive derivatives shipments to customers in Argentina, and up to date has exported a total of more... 
Via Benzinga
Blueberries Medical Reports Q1 2022 Financial Results, Eyes On Argentina's New Medicinal Market
On Monday, Blueberries Medical Corp. 
Via Benzinga
Blueberries Medical Reports 110% Revenue Growth In 2021
Blueberries Medical Corp. (OTCQB: BBRRF) (CSE: BBM) (FRA: 1OA) the Canadian parent of Blueberries S.A.S., reported its financial results for the year ended December 31, 2021. 2021 Financial Highlights 
Via Benzinga
The Week In Cannabis: Pfizer, Visa, $730M+ In Financings, Malta, EU, Columbia Care, MedMen, Uruguay And More
Below is a recap of the main news related to the cannabis industry and markets for the week of December 13, 2021. 
Via Benzinga
EXCLUSIVE: This Cannabis Company Becomes The First To Have THC, CBD Licenses In Uruguay
YVY Life Sciences recently became the first company in Uruguay to receive both medical THC and CBD produc... 
Via Benzinga
Exclusive: LatAm Cannabis Co. Terraflos, Founded By Former Congressman, Closes $8M Seed Funding Round
Terraflos, a medical cannabis company founded by former Argentine congressman 
Via Benzinga
Topics Cannabis
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.